Idioma:

Unique pharmacological actions of atypical neuroleptic quetiapine: possible role in cell cycle/fate control

Kondo, M A ; Tajinda, K ; Colantuoni, C ; Hiyama, H ; Seshadri, S ; Huang, B ; Pou, S ; Furukori, K ; Hookway, C ; Jaaro-Peled, H ; Kano, S-i ; Matsuoka, N ; Harada, K ; Ni, K ; Pevsner, J ; Sawa, A

Translational psychiatry, 2013-04, Vol.3 (4), p.e243-e243 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

Citações Citado por

Enviar para

Título:
Unique pharmacological actions of atypical neuroleptic quetiapine: possible role in cell cycle/fate control
Autor: Kondo, M A ; Tajinda, K ; Colantuoni, C ; Hiyama, H ; Seshadri, S ; Huang, B ; Pou, S ; Furukori, K ; Hookway, C ; Jaaro-Peled, H ; Kano, S-i ; Matsuoka, N ; Harada, K ; Ni, K ; Pevsner, J ; Sawa, A
Assuntos: Analysis of Variance ; Animals ; Antipsychotic Agents - pharmacology ; Astrocytes - metabolism ; Cell Cycle - drug effects ; Dibenzothiazepines - pharmacology ; Disease Models, Animal ; Frontal Lobe - drug effects ; Frontal Lobe - metabolism ; Gene Expression ; Haloperidol - pharmacology ; In Situ Hybridization ; Male ; Methamphetamine - administration & dosage ; Mice ; Neurons - metabolism ; Oligodendroglia - metabolism ; Original ; p21-Activated Kinases - genetics ; p21-Activated Kinases - metabolism ; Principal Component Analysis ; Quetiapine Fumarate ; Rats ; Rats, Sprague-Dawley ; Real-Time Polymerase Chain Reaction ; Schizophrenia - chemically induced ; Schizophrenia - metabolism
É parte de: Translational psychiatry, 2013-04, Vol.3 (4), p.e243-e243
Notas: Current address: Lieber Institute for Brain Development, Baltimore, MD, USA.
Descrição: Quetiapine is an atypical neuroleptic with a pharmacological profile distinct from classic neuroleptics that function primarily via blockade of dopamine D2 receptors. In the United States, quetiapine is currently approved for treating patients with schizophrenia, major depression and bipolar I disorder. Despite its widespread use, its cellular effects remain elusive. To address possible mechanisms, we chronically treated mice with quetiapine, haloperidol or vehicle and examined quetiapine-specific gene expression change in the frontal cortex. Through microarray analysis, we observed that several groups of genes were differentially expressed upon exposure to quetiapine compared with haloperidol or vehicle; among them, Cdkn1a, the gene encoding p21, exhibited the greatest fold change relative to haloperidol. The quetiapine-induced downregulation of p21/Cdkn1a was confirmed by real-time polymerase chain reaction and in situ hybridization. Consistent with single gene-level analyses, functional group analyses also indicated that gene sets associated with cell cycle/fate were differentially regulated in the quetiapine-treated group. In cortical cell cultures treated with quetiapine, p21/Cdkn1a was significantly downregulated in oligodendrocyte precursor cells and neurons, but not in astrocytes. We propose that cell cycle-associated intervention by quetiapine in the frontal cortex may underlie a unique efficacy of quetiapine compared with typical neuroleptics.
Editor: United States: Nature Publishing Group
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Anterior Resultado 2 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

Unique pharmacological actions of atypical neuroleptic quetiapine: possible role in cell cycle/fate control

Kondo, M A ; Tajinda, K ; Colantuoni, C ; Hiyama, H ; Seshadri, S ; Huang, B ; Pou, S ; Furukori, K ; Hookway, C ; Jaaro-Peled, H ; Kano, S-i ; Matsuoka, N ; Harada, K ; Ni, K ; Pevsner, J ; Sawa, A

United States: Nature Publishing Group

Buscando em bases de dados remotas. Favor aguardar.